Barclays’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $114M | Buy |
2,683,902
+327,343
| +14% | +$14.6M | 0.02% | 464 |
|
|
2026
Q1 | $114M | Buy |
2,356,559
+222,503
| +10% | +$10.4M | 0.03% | 451 |
|
|
2025
Q4 | $103M | Buy |
2,134,056
+485,505
| +29% | +$24.1M | 0.02% | 491 |
|
|
2025
Q3 | $77.8M | Buy |
1,648,551
+799,862
| +94% | +$38.6M | 0.02% | 591 |
|
|
2025
Q2 | $41M | Buy |
848,689
+318,173
| +60% | +$16.3M | 0.01% | 793 |
|
|
2025
Q1 | $29.4M | Sell |
530,516
-482,411
| -48% | -$26.1M | 0.01% | 858 |
|
|
2024
Q4 | $48.9M | Buy |
1,012,927
+373,155
| +58% | +$19M | 0.01% | 675 |
|
|
2024
Q3 | $36.9M | Buy |
639,772
+331,445
| +107% | +$17.9M | 0.01% | 794 |
|
|
2024
Q2 | $15M | Sell |
308,327
-173,131
| -36% | -$8.35M | ﹤0.01% | 1037 |
|
|
2024
Q1 | $23.4M | Buy |
481,458
+274,389
| +133% | +$13.4M | 0.01% | 917 |
|
|
2023
Q4 | $10.3M | Buy |
207,069
+20,876
| +11% | +$1.02M | ﹤0.01% | 1497 |
|
|
2023
Q3 | $9.99M | Buy |
186,193
+68,329
| +58% | +$3.64M | 0.01% | 994 |
|
|
2023
Q2 | $6.35M | Sell |
117,864
-86,338
| -42% | -$4.65M | ﹤0.01% | 1211 |
|
|
2023
Q1 | $11.1M | Sell |
204,202
-70,941
| -26% | -$3.45M | 0.01% | 1115 |
|
|
2022
Q4 | $13.3M | Sell |
275,143
-39,791
| -13% | -$1.75M | 0.01% | 1072 |
|
|
2022
Q3 | $12M | Sell |
314,934
-43,629
| -12% | -$1.94M | 0.01% | 802 |
|
|
2022
Q2 | $17.9M | Buy |
358,563
+223,305
| +165% | +$11.9M | 0.01% | 770 |
|
|
2022
Q1 | $6.95M | Buy |
135,258
+70,757
| +110% | +$3.65M | 0.01% | 1074 |
|
|
2021
Q4 | $3.23M | Sell |
64,501
-60,907
| -49% | -$3.01M | ﹤0.01% | 2037 |
|
|
2021
Q3 | $6.05M | Buy |
125,408
+52,816
| +73% | +$2.69M | ﹤0.01% | 1500 |
|
|
2021
Q2 | $3.82M | Buy |
72,592
+19,007
| +35% | +$992K | ﹤0.01% | 1753 |
|
|
2021
Q1 | $2.65M | Sell |
53,585
-56,341
| -51% | -$2.71M | ﹤0.01% | 2046 |
|
|
2020
Q4 | $5.34M | Sell |
109,926
-165,804
| -60% | -$8.18M | ﹤0.01% | 1481 |
|
|
2020
Q3 | $13.8M | Sell |
275,730
-97,920
| -26% | -$5.04M | 0.01% | 890 |
|
|
2020
Q2 | $19.1M | Buy |
373,650
+198,084
| +113% | +$9.63M | 0.01% | 662 |
|
|
2020
Q1 | $7.67M | Buy |
175,566
+125,807
| +253% | +$6.02M | 0.01% | 1162 |
|
|
2019
Q4 | $2.5M | Buy |
49,759
+37,984
| +323% | +$1.78M | ﹤0.01% | 2765 |
|
|
2019
Q3 | $546K | Sell |
11,775
-269,238
| -96% | -$11.6M | ﹤0.01% | 4179 |
|
|
2019
Q2 | $12.2M | Buy |
281,013
+211,958
| +307% | +$9.01M | 0.01% | 1230 |
|
|
2019
Q1 | $3.06M | Sell |
69,055
-44,334
| -39% | -$1.9M | ﹤0.01% | 2122 |
|
|
2018
Q4 | $4.92M | Sell |
113,389
-59,073
| -34% | -$2.61M | ﹤0.01% | 1615 |
|
|
2018
Q3 | $7.7M | Sell |
172,462
-273,544
| -61% | -$11.7M | 0.01% | 1446 |
|
|
2018
Q2 | $17.8M | Buy |
446,006
+204,737
| +85% | +$8.06M | 0.02% | 852 |
|
|
2018
Q1 | $9.67M | Buy |
241,269
+10,689
| +5% | +$445K | 0.01% | 1196 |
|
|
2017
Q4 | $9.91M | Buy |
230,580
+82,988
| +56% | +$3.83M | 0.01% | 1189 |
|
|
2017
Q3 | $7.35M | Sell |
147,592
-356,034
| -71% | -$17.2M | 0.01% | 1251 |
|
|
2017
Q2 | $24.1M | Buy |
503,626
+132,355
| +36% | +$6.33M | 0.03% | 515 |
|
|
2017
Q1 | $16.8M | Sell |
371,271
-26,796
| -7% | -$1.14M | 0.02% | 624 |
|
|
2016
Q4 | $16.1M | Buy |
398,067
+350,173
| +731% | +$13.8M | 0.02% | 697 |
|
|
2016
Q3 | $1.83M | Sell |
47,894
-9,437
| -16% | -$379K | ﹤0.01% | 2073 |
|
|
2016
Q2 | $2.4M | Sell |
57,331
-2,371,527
| -98% | -$97.2M | ﹤0.01% | 1863 |
|
|
2016
Q1 | $97.2M | Buy |
2,428,858
+1,848,450
| +318% | +$74.3M | 0.15% | 113 |
|
|
2015
Q4 | $24.4M | Sell |
580,408
-198,100
| -25% | -$9.11M | 0.03% | 506 |
|
|
2015
Q3 | $36.6M | Buy |
778,508
+606,002
| +351% | +$30.9M | 0.04% | 358 |
|
|
2015
Q2 | $8.46M | Sell |
172,506
-471,793
| -73% | -$23.9M | 0.01% | 1134 |
|
|
2015
Q1 | $31.6M | Buy |
644,299
+613,328
| +1,980% | +$29.3M | 0.04% | 482 |
|
|
2014
Q4 | $1.39M | Sell |
30,971
-53,178
| -63% | -$2.58M | ﹤0.01% | 2871 |
|
|
2014
Q3 | $4.71M | Sell |
84,149
-297,417
| -78% | -$16M | ﹤0.01% | 1836 |
|
|
2014
Q2 | $20.2M | Buy |
381,566
+372,808
| +4,257% | +$19.8M | 0.02% | 689 |
|
|
2014
Q1 | $453K | Sell |
8,758
-10,748
| -55% | -$544K | ﹤0.01% | 4052 |
|
|
2013
Q4 | $1.03M | Sell |
19,506
-427,597
| -96% | -$22.1M | ﹤0.01% | 3364 |
|
|
2013
Q3 | $22.4M | Buy |
447,103
+429,038
| +2,375% | +$21.8M | 0.03% | 609 |
|
|
2013
Q2 | $931K | Buy |
+18,065
| New | +$963K | ﹤0.01% | 3469 |
|
Other funds holding SNY
MIP
BIP
Barclays's SNY Position: Q2 2026 in Review
Barclays increased its Sanofi (SNY) stake by 14% in Q2 2026, buying an estimated $14.6M and bringing the position to 2,683,902 shares worth $114M. The position accounts for 0.02% of the portfolio, ranked #464.
Barclays first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Barclays held 2,683,902 shares of Sanofi worth $114M as of Q2 2026.
- Barclays bought 327,343 Sanofi shares in Q2 2026, an estimated $14.6M.
- Sanofi made up 0.02% of Barclays's portfolio in Q2 2026, its #464 holding.
- Barclays first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.